Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty.

Publisher: Walter de Gruyter Country of Publication: Germany NLM ID: 9508900 Publication Model: Print Cited Medium: Internet ISSN: 2191-0251 (Electronic) Linking ISSN: 0334018X NLM ISO Abbreviation: J Pediatr Endocrinol Metab Subsets: MEDLINE

Publication: Mar. 2011- : Berlin : Walter de Gruyter
Original Publication: London : Freund Pub. House, [1995-

Hormone Replacement Therapy*/adverse effects; Dwarfism, Pituitary/*drug therapy ; Human Growth Hormone/*therapeutic use ; Hypoglycemia/*prevention & control ; Hypogonadism/*prevention & control ; Hypopituitarism/*drug therapy ; Puberty, Delayed/*prevention & control; Age Factors ; Body Height/drug effects ; Child Development/drug effects ; Child, Preschool ; Cohort Studies ; Dwarfism, Pituitary/blood ; Dwarfism, Pituitary/physiopathology ; Female ; Human Growth Hormone/blood ; Human Growth Hormone/deficiency ; Human Growth Hormone/genetics ; Humans ; Hypoglycemia/etiology ; Hypogonadism/etiology ; Hypopituitarism/blood ; Hypopituitarism/physiopathology ; Infant ; Male ; Puberty, Delayed/etiology ; Recombinant Proteins/therapeutic use ; Retrospective Studies ; Turkey ; Weight Gain/drug effects

Background: The aim of the study was to assess the response to growth hormone (GH) treatment in very young patients with GH deficiency (GHD) through a national, multi-center study. Possible factors affecting growth response were assessed (especially mini-puberty).
Methods: Medical reports of GHD patients in whom treatment was initiated between 0 and 3 years of age were retrospectively evaluated.
Results: The cohort numbered 67. The diagnosis age was 12.4±8.6 months, peak GH stimulation test response (at diagnosis) as 1.0±1.4 ng/mL. The first and second years length gain was 15.0±4.3 and 10.4±3.4 cm. Weight gain had the largest effect on first year growth response; whereas weight gain and GH dose were both important factors affecting second year growth response. In the multiple pituitary hormone deficiency (MPHD) group (n=50), first year GH response was significantly greater than in the isolated GH deficiency (IGHD) group (n=17) (p=0.030). In addition first year growth response of infants starting GH between 0 and 12 months of age (n=24) was significantly greater than those who started treatment between 12 and 36 months of age (n=43) (p<0.001). These differences were not seen in the second year. Δ Length/height standard deviation score (SDS), Δ body weight SDS, length/height SDS, weight SDS in MPHD without hypogonadism for the first year of the GH treatment were found as significantly better than MPHD with hypogonadism.
Conclusions: Early onsets of GH treatment, good weight gain in the first year of the treatment and good weight gain-GH dose in the second year of the treatment are the factors that have the greatest effect on length gain in early onset GHD. The presence of the sex steroid hormones during minipubertal period influence growth pattern positively under GH treatment (closer to the normal percentage according to age and gender).

Karlberg J, Albertsson-Wikland K. Infancy growth pattern related to growth hormone deficiency. Acta Paediatr Scand 1988;77: 385–91.
Karlberg JA. Biologically-oriented mathematical model (ICP) for human growth. Acta Paediatr Scand 1989;350(Suppl):70–94.
Arrigo T, De Luca F, Bernasconi S, Bozzola M, Cavallo L, et al. Catch-up growth and height prognosis in early treated children with congenital hypopituitarism. Horm Res 1995;44(Suppl 3):26–31.
Argente J, Abusrewil SA, Bona G, Chiarelli F, Kelnar CJ, et al. Isolated growth hormone deficiency in children and adolescents. J Pediatr Endocrinol Metab 2001;14(Suppl 2):1003–8.
Binder G, Weidenkeller M, Blumenstock G, Langkamp M, Weber K, et al. Rational approach to the diagnosis of severe growth hormone deficiency in the newborn. J Clin Endocrinol Metab 2010;95:2219–26.
Achermann JC, Hughes IA. Disorders of sex development. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, editors. Williams textbook of endocrinology, 12th ed. Philadelphia, PA: Saunders Elsevier, 2011:863–94.
Kiviranta P, Kuiri-Hänninen T, Saari A, Lamidi ML, Dunkel L, et al. Transient postnatal gonadal activation and growth velocity in infancy. Pediatrics 2016;138:pii: e20153561. doi: 10.1542/peds.2015-3561.
Grumbach MM, Bin-Abbas BS, Kaplan SL. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm Res 1998;49(Suppl 2):41–57.
De Luca F, Arrigo T, Bozzola M, Crisafulli G, Ghizzoni L, et al. Hypopituitarism during the first year of life. A collaborative Italian study. Arch Pediatr 1998;5(Suppl 4):313–7.
Arrigo T, Bozzola M, Cavallo L, Ghizzoni L, Maghnie M, et al. Growth hormone deficient children treated from before two years old fail to catch-up completely within five years of treatment. J Pediatr Endocrinol Metab 1998;11:45–50.
Wasniewska M, Arrigo T, Cisternino M, De Luca F, Ghizzoni L, et al. Birth weight influences long-term catch-up growth and height prognosis of GH-deficient children treated before the age of 2 years. Eur J Endocrinol 2000;142:460–5.
Achermann JC, Hamdani K, Hindmarsh PC, Brook CG. Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children. Pediatrics 1998;102(2 Pt 1):342–5.
Breier BH, Gluckman PD. The regulation of postnatal growth: nutritional influences on endocrine pathways and function of the somatotrophic axis. Livest Prod Sci 1991;27;77–94.
Boersma B, Rikken B, Wit JM. Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group. Arch Dis Child 1995;72:427–31.
Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, et al. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0–3 years) with idiopathic GH deficiency: analysis of data from KIGS. J Clin Endocrinol Metab 2005;90:1966–71.
Root AW, Dana K, Lippe B. Treatment of growth hormone-deficient infants with recombinant human growth hormone to near-adult height: patterns of growth. Horm Res Paediatr 2011;75:276–83.
Huet F, Carel JC, Nivelon JL, Chaussain JL. Long-term results of GH treatment in GH-deficient children treated before 1 year of age. Eur J Endocrinol 1999;140:29–34.
Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, et al. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. J Clin Endocrinol Metab 1997;82:452–6.

Keywords: growth hormone deficiency; growth hormone treatment; growth response; infancy; mini-puberty

0 (Recombinant Proteins)
12629-01-5 (Human Growth Hormone)

Combined Pituitary Hormone Deficiency

Date Created: 20180122 Date Completed: 20180905 Latest Revision: 20210213

20240829

10.1515/jpem-2017-0123

29353264